Talk with your healthcare provider to see if one of these medications might be right for you
For others, it may be combined with or transitioned alongside other medications such as Qsymia, depending on how your body responds
The lawsuit further alleges that Defendants: Marketed unapproved oral tirzepatide tablets and ODT-style dissolving tablets Represented these compounded products as legitimate GLP-1 weight-loss medications Used telehealth storefronts and shell websites to create the appearance of independent providers Issued prescriptions through an automated process with little or no medical review Dispensed the tablets through Triad Rx or Triad Rx Buyer LLC Misled consumers into believing the tablets were safe, effective, FDA-compliant, or equivalent to Mounjaro, Zepbound, or Rybelsus Consumers have reported that these tablets were ineffective, unsafe, improperly compounded, or distributed without any genuine medical evaluation
High Cost Not Impacting Demand GLP-1 medications, originally developed to manage Type 2 diabetes, became popular for its off-label effect on weight loss